(BCS) Barclays - Overview
Sector: Financial Services | Industry: Banks - Diversified | Exchange: NYSE (USA) | Market Cap: 80.818m USD | Total Return: 32.6% in 12m
Retail Banking, Investment Banking, Credit Cards, Wealth Management
Total Rating 32
Safety 35
Buy Signal -0.11
Banks - Diversified
Industry Rotation: -3.7
Industry Rotation: -3.7
Market Cap:
80.8B
Avg Turnover: 145M
Avg Turnover: 145M
Risk 3d forecast
Volatility33.4%
VaR 5th Pctl6.14%
VaR vs Median11.7%
Reward TTM
Sharpe Ratio1.00
Rel. Str. IBD46.2
Rel. Str. Peer Group24
Character TTM
Beta1.074
Beta Downside0.870
Hurst Exponent0.576
Drawdowns 3y
Max DD26.20%
CAGR/Max DD1.78
CAGR/Mean DD8.56
EPS (Earnings per Share)
EPS CAGR: 27.15%
EPS Trend: 37.8%
EPS Trend: 37.8%
Last SUE: 0.30
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 19.43%
Rev. Trend: 61.6%
Rev. Trend: 61.6%
Last SUE: 0.00
Qual. Beats: 0
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: BCS Barclays
Barclays PLC (BCS) is a London-based global financial institution operating across five primary segments: Barclays UK, Barclays UK Corporate Bank, Private Bank and Wealth Management, Investment Bank, and US Consumer Bank. Founded in 1690, the firm provides a comprehensive suite of services including retail and wholesale banking, credit cards, mortgage lending, and securities dealing across major international markets.
The company utilizes a universal banking model, which aims to balance cyclical retail interest income with fee-based revenue from investment banking and wealth management operations. As a member of the Diversified Banks sub-industry, Barclays is subject to stringent capital adequacy requirements and global regulatory oversight common to Systemically Important Financial Institutions (SIFIs).
To better understand how these revenue streams impact long-term valuation, consider reviewing the detailed financial metrics available on ValueRay. This summary reflects the companys established position as a primary provider of credit and capital markets infrastructure in the United Kingdom and the United States.
- Investment Bank trading volatility and advisory fees drive non-interest income performance
- Bank of England interest rate policy shifts impact net interest margin spreads
- UK mortgage market competition and consumer credit quality influence loan loss provisions
- Strategic cost reduction initiatives and structural simplification targets improve return on equity
- US consumer credit card portfolio growth and delinquency rates affect international revenue
Piotroski VR‑10 (Strict)
5.0
| Net Income: 7.23b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -0.82 > 1.0 |
| NWC/Revenue: -858.0% < 20% (prev -780.1%; Δ -77.85% < -1%) |
| CFO/TA 0.02 > 3% & CFO 39.04b > Net Income 7.23b |
| Net Debt (-289.56b) to EBITDA (9.21b): -31.44 < 3 |
| Current Ratio: 0.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.43b) vs 12m ago -4.11% < -2% |
| Gross Margin: 91.39% > 18% (prev 0.92%; Δ 9.05k% > 0.5%) |
| Asset Turnover: 1.74% > 50% (prev 1.69%; Δ 0.04% > 0%) |
| Interest Coverage Ratio: 0.42 > 6 (EBITDA TTM 9.21b / Interest Expense TTM 21.69b) |
Altman Z''
-0.76
| A: -0.14 (Total Current Assets 426.63b - Total Current Liabilities 671.67b) / Total Assets 1694.79b |
| B: 0.03 (Retained Earnings 58.84b / Total Assets 1694.79b) |
| C: 0.01 (EBIT TTM 9.21b / Avg Total Assets 1644.14b) |
| D: 0.04 (Book Value of Equity 63.06b / Total Liabilities 1617.67b) |
| Altman-Z'' Score: -0.76 = CCC |
What is the price of BCS shares?
As of May 17, 2026, the stock is trading at USD 22.53 with a total of 5,609,268 shares traded.
Over the past week, the price has changed by -4.98%, over one month by -5.77%, over three months by -12.17% and over the past year by +32.56%.
Over the past week, the price has changed by -4.98%, over one month by -5.77%, over three months by -12.17% and over the past year by +32.56%.
Is BCS a buy, sell or hold?
Barclays has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy BCS.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BCS price?
| Analysts Target Price | 26.9 | 19.5% |
Barclays (BCS) - Fundamental Data Overview
as of 12 May 2026
Market Cap GBP = 59.72b (80.82b USD * 0.739 USD.GBP)P/E Trailing = 10.0466
P/E Forward = 8.4531
P/S = 2.9831
P/B = 0.7756
P/EG = 1.4087
Revenue TTM = 28.56b GBP
EBIT TTM = 9.21b GBP
EBITDA TTM = 9.21b GBP
Long Term Debt = 76.70b GBP (from longTermDebt, last fiscal year)
Short Term Debt = 73.13b GBP (from shortTermDebt, last fiscal year)
Debt = 136.84b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -289.56b GBP (recalculated: Debt 136.84b - CCE 426.40b)
Enterprise Value = 59.72b GBP (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.42 (Ebit TTM 9.21b / Interest Expense TTM 21.69b)
EV/FCF = -7.40x (Enterprise Value 59.72b / FCF TTM -8.07b)
FCF Yield = -13.51% (FCF TTM -8.07b / Enterprise Value 59.72b)
FCF Margin = -28.26% (FCF TTM -8.07b / Revenue TTM 28.56b)
Net Margin = 25.33% (Net Income TTM 7.23b / Revenue TTM 28.56b)
Gross Margin = 91.39% ((Revenue TTM 28.56b - Cost of Revenue TTM 2.46b) / Revenue TTM)
Gross Margin QoQ = 89.68% (prev 92.30%)
Tobins Q-Ratio = 0.04 (Enterprise Value 59.72b / Total Assets 1694.79b)
Interest Expense / Debt = 15.85% (Interest Expense 21.69b / Debt 136.84b)
Taxrate = 22.67% (651.9m / 2.88b)
NOPAT = 7.12b (EBIT 9.21b * (1 - 22.67%))
Current Ratio = 0.64 (Total Current Assets 426.63b / Total Current Liabilities 671.67b)
Debt / Equity = 1.78 (Debt 136.84b / totalStockholderEquity, last quarter 76.67b)
Debt / EBITDA = -31.44 (Net Debt -289.56b / EBITDA 9.21b)
Debt / FCF = 35.88 (negative FCF - burning cash) (Net Debt -289.56b / FCF TTM -8.07b)
Total Stockholder Equity = 76.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.44% (Net Income 7.23b / Total Assets 1694.79b)
RoE = 9.43% (Net Income TTM 7.23b / Total Stockholder Equity 76.69b)
RoCE = 6.00% (EBIT 9.21b / Capital Employed (Equity 76.69b + L.T.Debt 76.70b))
RoIC = 3.16% (NOPAT 7.12b / Invested Capital 225.30b)
WACC = 11.50% (E(59.72b)/V(196.56b) * Re(9.76%) + D(136.84b)/V(196.56b) * Rd(15.85%) * (1-Tc(0.23)))
Discount Rate = 9.76% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.67 | Cagr: -48.23%
[DCF] Fair Price = unknown (Cash Flow -8.07b)
EPS Correlation: 37.80 | EPS CAGR: 27.15% | SUE: 0.30 | # QB: 0
Revenue Correlation: 61.62 | Revenue CAGR: 19.43% | SUE: 0.00 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.82 | Chg30d=+3.36% | Revisions=+20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.72 | Chg30d=-1.28% | Revisions=-20% | Analysts=1
EPS current Year (2026-12-31): EPS=2.85 | Chg30d=-0.49% | Revisions=+0% | GrowthEPS=+22.4% | GrowthRev=+6.5%
EPS next Year (2027-12-31): EPS=3.39 | Chg30d=+1.34% | Revisions=+33% | GrowthEPS=+19.1% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: +33%